Back to Venrock Adviser, LLC
Q2 2026 13F filing
Updated 27 days ago33 disclosed positions worth $3.3B
Portfolio value
$3.3B
Total holdings
33
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-08-14
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A APGE APOGEE THERAPEUTICS INC | $1.1B | 8.49M | 34.18% | — |
| 2 | O ORKA ORUKA THERAPEUTICS INC | $394.8M | 4.15M | 11.97% | — |
| 3 | E EQR ERASCA INC | $327.8M | 17.89M | 9.94% | — |
| 4 | S SYRE SPYRE THERAPEUTICS INC | $265M | 2.99M | 8.04% | — |
| 5 | D DNTH DIANTHUS THERAPEUTICS INC | $115M | 1.18M | 3.49% | — |
| 6 | O OCFC OCULAR THERAPEUTIX INC | $101.6M | 10.35M | 3.08% | — |
| 7 | ? N/A DAMORA THERAPEUTICS INC | $93.7M | 3.60M | 2.84% | — |
| 8 | S SVRA SAVARA INC | $90.8M | 14.75M | 2.75% | — |
| 9 | J JBIO JADE BIOSCIENCES INC | $71.6M | 3.22M | 2.17% | — |
| 10 | C COGT COGENT BIOSCIENCES INC | $63.6M | 1.64M | 1.93% | — |
| 11 | V VRDN VIRIDIAN THERAPEUTICS INC | $59.8M | 3.26M | 1.81% | — |
| 12 | V VOR VOR BIOPHARMA INC | $56M | 3.04M | 1.70% | — |
| 13 | D DYN DYNE THERAPEUTICS INC | $48.3M | 2.17M | 1.46% | — |
| 14 | M MAZE MAZE THERAPEUTICS INC | $47.8M | 1.60M | 1.45% | — |
| 15 | R RLMD RELMADA THERAPEUTICS INC | $47.4M | 6.84M | 1.44% | — |
| 16 | O ORIC ORIC PHARMACEUTICALS INC | $46.8M | 4.32M | 1.42% | — |
| 17 | ? N/A CRESCENT BIOPHARMA INC. | $38.4M | 2.13M | 1.16% | — |
| 18 | Z ZURA ZURA BIO LTD | $38M | 6.43M | 1.15% | — |
| 19 | A ANL ADLAI NORTYE LTD | $36.9M | 3.21M | 1.12% | — |
| 20 | E ELVN ENLIVEN THERAPEUTICS INC | $26.7M | 526.3K | 0.81% | — |
| 21 | H HELP CYBIN INC | $25.5M | 3.85M | 0.77% | — |
| 22 | C CGEM CULLINAN THERAPEUTICS INC | $25.1M | 1.38M | 0.76% | — |
| 23 | C CRNC CENTURY THERAPEUTICS INC | $21.3M | 8.70M | 0.65% | — |
| 24 | ? N/A ARTIVA BIOTHERAPEUTICS INC | $19.8M | 2.04M | 0.60% | — |
| 25 | C CTMX CYTOMX THERAPEUTICS INC | $18.7M | 4.98M | 0.57% | — |
| 26 | A ACHV ACHIEVE LIFE SCIENCE INC | $18M | 2.75M | 0.54% | — |
| 27 | P PBLS PARABILIS MEDICINES INC | $17.1M | 625.0K | 0.52% | — |
| 28 | ? N/A SURROZEN INC | $16.4M | 632.9K | 0.50% | — |
| 29 | K KRRO KORRO BIO INC | $13.3M | 1.01M | 0.40% | — |
| 30 | A ANRO ALTO NEUROSCIENCE INC | $13.2M | 500.0K | 0.40% | — |
| 31 | ? N/A X4 PHARMACEUTICALS INC | $9M | 1.93M | 0.27% | — |
| 32 | R RACC RESEARCH ALLIANCE CORP III | $3.2M | 300.0K | 0.10% | — |
| 33 | I INM INMED PHARMACEUTICALS INC | $51K | 32.7K | 0.00% | — |